Campbell's (CPB) reported Q3 2025 revenue of $2.48 billion, a 4.5% increase year-over-year and above the consensus estimate of $2.44 billion, with EPS at $0.73, slightly below the previous year's $0.75 but exceeding estimates by 12.31%; Meals & Beverages sales rose 15% to $1.46 billion, while Snacks sales declined 7.8% to $1.01 billion. Despite exceeding overall revenue expectations, Campbell's stock has underperformed the S&P 500 over the past month and carries a Zacks Rank #4 (Sell), suggesting potential near-term underperformance.
Campbell Soup Company (CPB) reported mixed financial results for its third quarter ending April 2025. Total revenue increased by 4.5% year-over-year to $2.48 billion, exceeding the Zacks Consensus Estimate of $2.44 billion by 1.55%. While reported EPS of $0.73 surpassed the consensus estimate of $0.65 by a notable 12.31%, it marked a decrease from the $0.75 EPS recorded in the comparable quarter of the previous year. Segment performance highlighted divergent trends: Net Sales in the Meals & Beverages division grew a strong 15% year-over-year to $1.46 billion, outperforming the $1.41 billion analyst estimate. In contrast, the Snacks division saw Net Sales decline by 7.8% year-over-year to $1.01 billion, falling short of the $1.03 billion estimate. Operating earnings for Meals & Beverages were $248 million, largely in line with the $248.40 million estimate, whereas Snacks operating earnings of $145 million exceeded the $137.08 million consensus. A significant area of concern was Corporate operating earnings, which posted a loss of $226 million, substantially higher than the estimated loss of $42.90 million. This performance has occurred while CPB shares returned -5.1% over the past month, underperforming the Zacks S&P 500 composite's +6.1% gain, and the stock currently holds a Zacks Rank #4 (Sell), suggesting potential for continued underperformance in the near term.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
-0.15
Ticker Sentiment